Share useful research with your peers
in · Share on LinkedIn ↗
COMPANY RESEARCH

Chongqing Zhifei Biological Products Co., Ltd.

Chongqing Zhifei Biological Products is a Chinese listed vaccine and biopharmaceutical developer engaged in vaccine research, development, manufacturing and commercialization. Its scientific activities include recombinant and other vaccine technologies, with work aimed at prevention of infectious diseases. The company combines proprietary development with external collaborations and licensed vaccine commercialization, requiring its original R&D activity to be distinguished from distribution-only operations. Zhifei is based in Chongqing, China, and its shares trade on the Shenzhen Stock Exchange under security code 300122.

Company at a glance

Corporate information

Company entity
Chongqing Zhifei Biological Products Co., Ltd.
Founded
Not verified
Ownership / capital status
Publicly tradedPublicly listed
LinkedIn company page
Independent company page not verified

Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.

Listed issuer and R&D focus

SZSE: 300122

vaccine research · recombinant proteins · mRNA vaccines

infectious diseases · preventive vaccines

Last independently verified:

Disease tags match recorded text mentions and require program-level verification.

Technology, programs & evidence

Chongqing Zhifei Biological Products is a Chinese listed vaccine and biopharmaceutical developer engaged in vaccine research, development, manufacturing and commercialization. Its scientific activities include recombinant and other vaccine technologies, with work aimed at prevention of infectious diseases. The company combines proprietary development with external collaborations and licensed vaccine commercialization, requiring its original R&D activity to be distinguished from distribution-only operations. Zhifei is based in Chongqing, China, and its shares trade on the Shenzhen Stock Exchange under security code 300122.

Business, technology & evidence

  • SecuritiesSZSE: 300122

Individual program detail is not recorded. Consult the original sources below.

Related news & literature

Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.

Showing 0 / 0 related items

No cataloged update explicitly mentions this company.

Same-field reading (not company-specific)

Research this company together

Discussions are for signed-in members. Personal notes remain separate from company research.

Sign in to join

Sources & open questions

    1. Official issuer and R&D disclosure · Chongqing Zhifei Biological Products Co., Ltd. ↗Chongqing Zhifei Biological Products Co., Ltd. ·
    2. Official issuer and R&D disclosure · Chongqing Zhifei Biological Products Co., Ltd. ↗Chongqing Zhifei Biological Products Co., Ltd. ·

    Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.

    AI assistant ↗